Cardinal Health (CAH) awards 54,823 performance share units to segment CEO

Rhea-AI Filing Summary

WEITZMAN DEBORAH reported acquisition or exercise transactions in this Form 4 filing.

Cardinal Health executive Deborah Weitzman, CEO of the Pharmaceutical & Specialty Solutions segment, received an equity compensation award of 54,823 performance share units on August 4, 2026. These units represent rights to receive common shares and are scheduled to settle on August 15, 2026.

Following this grant, her reported direct holdings in Cardinal Health common shares increased to 107,700 shares. The award was recorded at a price of $0.0000 per share, reflecting that it was a compensation grant rather than an open‑market purchase.

Insider Trade Summary

Net Buyer: 54,823 shares

Net Buy 1 txn

Insider WEITZMAN DEBORAH

Role CEO, PSS Segment

Type	Security	Shares	Price	Value
Grant/Award	Common Shares F1	54,823	$0.00	$0.00

Holdings After Transaction: Common Shares — 107,700 shares (Direct)

Footnotes (1)

1. F1. Reflects performance share units that will settle on August 15, 2026.

Key Figures

Performance share units granted: 54,823 shares Direct holdings after transaction: 107,700 shares Settlement date of performance units: August 15, 2026 +1 more

4 metrics

Performance share units granted 54,823 shares Grant to Deborah Weitzman on 2026-08-04

Direct holdings after transaction 107,700 shares Reported common share holdings following the award

Settlement date of performance units August 15, 2026 Date when granted performance share units will settle

Recorded grant price per share $0.0000 per share Compensation award of performance share units, not an open-market purchase

Key Terms

performance share units, settle, Common Shares

3 terms

performance share units financial

"Reflects performance share units that will settle on August 15, 2026."

Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.

settle financial

"Reflects performance share units that will settle on August 15, 2026."

Common Shares financial

"security_title: Common Shares, non-derivative transaction"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/06/2026 - 06:06 AM Accepted by SEC EDGAR 08/06/2026 - 06:04 AM Learn about SEC filing dates

FAQ

What insider equity award did CAH report for Deborah Weitzman?

Cardinal Health reported that Deborah Weitzman received an equity award of 54,823 performance share units on August 4, 2026. These units represent rights to Cardinal Health common shares as part of her compensation package.

How many Cardinal Health (CAH) shares does Deborah Weitzman hold after this Form 4?

After the reported grant, Deborah Weitzman is shown as directly holding 107,700 Cardinal Health common shares. This figure reflects her position immediately following the August 4, 2026 performance share unit award.

When will Deborah Weitzman’s new performance share units in CAH settle?

The 54,823 performance share units granted to Deborah Weitzman are scheduled to settle on August 15, 2026. At settlement, the units are expected to convert into Cardinal Health common shares, subject to the award terms.

Was the Cardinal Health (CAH) Form 4 transaction an open-market purchase or a grant?

The Form 4 reports a grant or award acquisition, not an open‑market purchase. 54,823 performance share units were awarded at a recorded price of $0.0000 per share as part of equity compensation.

Is Deborah Weitzman’s CAH equity award reported under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the transaction is recorded as a grant or award rather than a discretionary trade, indicating it is standard compensation rather than plan-based selling or buying.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WEITZMAN DEBORAH

(Last) (First) (Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN OHIO 43017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, PSS Segment

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/04/2026		A(1)		54,823	A	$0	107,700	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects performance share units that will settle on August 15, 2026.

Remarks:

	/s/ Laura C. Dhaliwal, Attorney-in-fact	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)